Phase I Treatment of Adults With Primary Malignant Glioma With Topotecan (NSC #609699) Plus BCNU (NSC #409962).
Phase of Trial: Phase I
Latest Information Update: 19 Feb 2013
At a glance
- Drugs Carmustine (Primary) ; Topotecan (Primary)
- Indications Glioma
- Focus Adverse reactions
- 16 Dec 2011 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Apr 2003).
- 13 Dec 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 11 Sep 2005 New trial record.